LifeCycle Pharma Receives Notice of Allowance for U.S. Patent on Fenoglide(R)

COPENHAGEN, Denmark, Dec. 17, 2009 (GLOBE NEWSWIRE) -- LifeCycle Pharma A/S (Copenhagen:LCP) announced today that the United States Patent and Trademark Office (USPTO) has issued a Notice of Allowance for LCP's U.S. patent application directed to LCP's fenofibrate tablet.

Back to news